www.fdanews.com/articles/196053-ibex-earns-ce-mark-for-cancer-detection-software
Ibex Earns CE Mark for Cancer Detection Software
February 28, 2020
Ibex gained CE Mark certification for Galen Prostate, its AI-powered cancer detection software cleared for detecting and assessing prostate cancer.
The technology helps “ensure diagnostic accuracy, integrate comprehensive quality control and enable a more efficient workflow,” the company said.
The solution uses an algorithm formulated from a dataset of more than 60,000 prostate slides that include a variety of diagnoses and clinical findings.